YS Biopharma

$YS is up nearly 50% and leading the Prism MarketView Biotech index after the announcement that people inside the company are purchasing shares. However the gap up in price so far has just gone to where the stock was already trading just a few weeks ago

Share This Article

 

About the Author

YS Biopharma

Joey Ramson